Reply to Talarico et al.'s comment: "Rate of serious infections in patients with rheumatoid arthritis receiving tumor necrosis factor (TNF)-alpha antagonist: a prospective observational study"

Joint Bone Spine. 2014 Jul;81(4):379-80. doi: 10.1016/j.jbspin.2014.04.003. Epub 2014 Jun 21.

Authors

Helene Che¹, Cedric Lukas², Jacques Morel², Bernard Combe²

Affiliations

¹ Department of Rheumatology, Lapeyronie Hospital, University of Montpellier 1, 34295 Montpellier cedex 5, France. Electronic address: [email protected].
² Department of Rheumatology, Lapeyronie Hospital, University of Montpellier 1, 34295 Montpellier cedex 5, France.

PMID: 24962980
DOI: 10.1016/j.jbspin.2014.04.003

No abstract available

Keywords: Anti-TNF alpha therapy; Infections; Rheumatoid arthritis.

Publication types

Letter
Comment

MeSH terms

Antirheumatic Agents / adverse effects*
Arthritis, Rheumatoid / drug therapy*
Herpesviridae Infections / etiology*
Humans

Substances

Antirheumatic Agents